Transcriptional Reprogramming Using a New Dual NIS Agonist Enhances Radioiodide Uptake and Facilitates Greater Predictive Utility for Thyroid Cancer Recurrence

Martin Read*, Katie Brookes, Ling Zha, Jana Kim, Jessica Fear, Sarinya Wongsanit, Benjamin Small, Hannah Nieto, Vinodh Kannappan, Weiguang Wang, Sissy Jhiang, Matthew Ringel, Moray Campbell, Kavitha Sunassee, Philip Blower, Kristien Boelaert, Vicki Smith, Christopher McCabe

*Corresponding author for this work

Research output: Contribution to journalAbstractpeer-review

Original languageEnglish
Article numberPoster 0201
Pages (from-to)A49-A50
Number of pages2
JournalThyroid
Volume34
Issue numberS1
DOIs
Publication statusPublished - 25 Oct 2024
Event2024 American Thyroid Association Annual Conference - Sheraton Grand Chicago Riverwalk, Chicago, United States
Duration: 30 Oct 20243 Nov 2024
Conference number: 93
https://www.thyroid.org/2024-annual-meeting/

Fingerprint

Dive into the research topics of 'Transcriptional Reprogramming Using a New Dual NIS Agonist Enhances Radioiodide Uptake and Facilitates Greater Predictive Utility for Thyroid Cancer Recurrence'. Together they form a unique fingerprint.

Cite this